Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 6.
B
Brickman, JM;
Clements, M;
Tyrell, R;
McNay, D;
Woods, K;
Warner, J;
Stewart, A;
... Dattani, M; + view all
(2001)
Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders.
DEVELOPMENT
, 128
(24)
5189 - 5199.
|
 |
C
|
Clark, RE;
Dodi, IA;
Hill, SC;
Lill, JR;
Aubert, G;
Macintyre, AR;
Rojas, J;
... Madrigal, JA; + view all
(2001)
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein.
Blood
, 98
(10)
pp. 2887-2893.
|
|
H
|
Huntly, BJP;
Reid, AG;
Bench, AJ;
Campbell, LJ;
Telford, N;
Shepherd, P;
Szer, J;
... Green, AR; + view all
(2001)
Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia.
BLOOD
, 98
(6)
1732 - 1738.
|
|
J
|
Jones, DT;
Ganeshaguru, K;
Virchis, AE;
Folarin, NI;
Lowdell, MW;
Mehta, AB;
Prentice, HG;
... Wickremasinghe, RG; + view all
(2001)
Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation.
Blood
, 98
(9)
pp. 2800-2807.
10.1182/blood.v98.9.2800.
|
|
M
|
Mainwaring, P.N.;
Cunningham, D.;
Gregory, W.;
Hoskin, P.;
Hancock, B.;
Norton, A.J.;
MacLennan, K.;
... Linch, D.; + view all
(2001)
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.
Blood
, 97
(10)
pp. 2991-2997.
10.1182/blood.V97.10.2991.
|
|
N
|
Nathwani, AC;
Davidoff, A;
Hanawa, H;
Zhou, JF;
Vanin, EF;
Nienhuis, AW;
(2001)
Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.
Blood
, 97
(5)
pp. 1258-1265.
10.1182/blood.v97.5.1258.
|
|
